Exciting New Uses of Botulinum Toxin Type A: Dermatology/Dermatologic Surgery and Beyond

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Unknown venue

• Publication date

  2017-06-23

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/9781118661833.CH25
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Botulinum Toxin A: An Effective Treatment for Linear Immunoglobulin A Bullous Dermatosis Located in the Axillae.

  2016cited by this paper
• Botulinum Toxin A in Postherpetic Neuralgia: A Parallel, Randomized, Double-Blind, Single-Dose, Placebo-controlled Trial

  2013cited by this paper
• Short-Term Autonomic Denervation of the Atria Using Botulinum Toxin

  2010cited by this paper
• Failure of botulinum toxin treatment for localized vitiligo.

  2010cited by this paper
• Predicting migraine responsiveness to botulinum toxin type A injections.

  2010cited by this paper
• Effect of Botulinum Toxin Type A on Transforming Growth Factor β1 in Fibroblasts Derived from Hypertrophic Scar: A Preliminary Report

  2010cited by this paper
• Atrial fibrillation after cardiac surgery.

  2010cited by this paper
• Botulinum toxin type A for neuropathic itch

  2010cited by this paper
• Use of anatomic measurement to guide injection of botulinum toxin for the management of chronic lateral epicondylitis: a randomized controlled trial

  2010cited by this paper
• Cost effectiveness of botulinum toxins for the treatment of depression: preliminary observations.

  2010cited by this paper
• Botulinum toxin-A injection may be beneficial in the treatment of life-long premature ejaculation.

  2010cited by this paper
• Efficacy and duration of botulinum toxin treatment for drooling in 131 children.

  2010cited by this paper
• Mechanisms of prostate atrophy after glandular botulinum neurotoxin type a injection: an experimental study in the rat.

  2009cited by this paper
• Treatment of granulosis rubra nasi with botulinum toxin type A.

  2009cited by this paper
• Severe post-herpetic neuralgia successfully treated with botulinum toxin A: three case reports.

  2009cited by this paper
• Another Test of the Passive Facial Feedback Hypothesis: When Your Face Smiles, You Feel Happy

  2009cited by this paper
• Treatment of Hypertrophic Scars With Intralesional Botulinum Toxin Type A Injections: A Preliminary Report

  2009cited by this paper
• Intra-articular Botulinum Toxin Type A: a new approach to treat arthritis joint pain.

  2009cited by this paper
• Use of botulinum toxin in cheiloplasty: A new method to decrease tension

  2009cited by this paper
• Treatment for multiple periorbital eccrine hidrocystomas: botulinum toxin A.

  2009cited by this paper
• Treatment of epidermolysis bullosa simplex, Weber-Cockayne type, with botulinum toxin type A.

  2009cited by this paper
• Botox Therapy for Ischemic Digits

  2009cited by this paper
• Botulinum Toxin: A Treatment for Compensatory Hyperhidrosis in the Trunk

  2009cited by this paper
• The Use of Botulinum Toxin in the Treatment of a Parotid Duct Injury During Mohs Surgery and Review of Management Options

  2009cited by this paper
• Botulinum toxin type A in the healing of a chronic buttock ulcer in a patient with spastic paraplegia after spinal cord injury.

  2009cited by this paper
• Botulinum Toxin Type A – Treatment of a Patient with Multiple Cutaneous Piloleiomyomas

  2008cited by this paper
• Botulinum toxin type A for the preventive treatment of intertrigo in a patient with Darier's disease and inguinal hyperhidrosis.

  2008cited by this paper
• Botulinum toxin and the facial feedback hypothesis: can looking better make you feel happier?

  2008cited by this paper
• Relief of intractable pruritus after administration of botulinum toxin A (botox): a case report.

  2008cited by this paper
• Botulinum toxin type‐A for the treatment of inverse psoriasis

  2008cited by this paper
• The evolution of botulinum neurotoxin type A for cosmetic applications

  2007cited by this paper
• Management of Vasospastic Disorders with Botulinum Toxin A

  2007cited by this paper
• Synaptobrevin I mediates exocytosis of CGRP from sensory neurons and inhibition by botulinum toxins reflects their anti-nociceptive potential

  2007cited by this paper
• Making scents: improvement of olfactory profile after botulinum toxin-A treatment in healthy individuals.

  2007cited by this paper
• Why the most potent toxin may heal anal fissure

  2006cited by this paper
• Novel cutaneous uses for botulinum toxin type A

  2006cited by this paper
• Neurophysiological, neuroimmunological, and neuroendocrine basis of pruritus.

  2006cited by this paper
• Treatment of Depression with Botulinum Toxin A: A Case Series

  2006cited by this paper
• A review of the current uses of Botox for dentally-related procedures.

  2006cited by this paper
• Neuroanatomy and neurophysiology of itch

  2005cited by this paper
• Botulinum Toxin for the Treatment of Facial Flushing

  2004cited by this paper
• Subcutaneous administration of botulinum toxin A reduces formalin‐induced pain

  2004cited by this paper
• The Therapeutic Potential of Botulinum Toxin

  2004cited by this paper
• Activation/deactivation of acetylcholinesterase by H2O2: more evidence for oxidative stress in vitiligo.

  2004cited by this paper
• Noncosmetic uses of botulinum toxin.

  2004cited by this paper
• Botulinum Toxin Infiltration for Pain Control After Mastectomy and Expander Reconstruction

  2004cited by this paper
• Regulation of Calcitonin Gene‐Related Peptide Secretion From Trigeminal Nerve Cells by Botulinum Toxin Type A: Implications for Migraine Therapy

  2004cited by this paper
• Pharmacologic denervation of frown muscles enhances baseline expression of happiness and decreases baseline expression of anger, sadness, and fear.

  2003cited by this paper
• Botulinum toxin type A (BOTOX) for treatment of migraine.

  2002cited by this paper
• Botulinum toxin type A injection in the treatment of lichen simplex: an open pilot study.

  2002cited by this paper
• Adjuvant botulinum toxin A in dyshidrotic hand eczema: a controlled prospective pilot study with left–right comparison

  2002cited by this paper
• Treatment of dyshidrotic hand dermatitis with intradermal botulinum toxin.

  2002cited by this paper
• Management of salivary fistula with botulinum toxin type A

  2001cited by this paper
• Intracutaneous botulinum toxin A versus ablative therapy of Hailey-Hailey disease - a case report

  2001cited by this paper
• Identification and characterization of muscarinic acetylcholine receptor subtypes expressed in human skin melanocytes

  2001cited by this paper
• Mechanisms of pain

  2001cited by this paper
• Capsaicin-stimulated release of substance P from cultured dorsal root ganglion neurons: involvement of two distinct mechanisms.

  2000cited by this paper
• Botulinum toxin treatment for symptomatic Frey's syndrome

  2000cited by this paper
• Botox and the management of pectoral spasm after subpectoral implant insertion.

  2000cited by this paper
• [Presynaptic effects of botulinum toxin type A on the neuronally evoked response of albino and pigmented rabbit iris sphincter and dilator muscles].

  2000cited by this paper
• Capsaicin stimulates release of substance P from dorsal root ganglion neurons via two distinct mechanisms.

  1997cited by this paper
• IL-1 alpha, IL-1 beta and psoriasis: conflicting results in the literature. Opposite behaviour of the two cytokines in lesional or non-lesional extracts of whole skin.

  1997cited by this paper
• Calcitonin gene-related peptide: possible role in formation and maintenance of neuromuscular junctions

  1995cited by this paper
• Hailey–Hailey disease: the clinical features, response to treatment and prognosis

  1992cited by this paper
• Neuropeptides in psoriasis: an immunocytochemical and radioimmunoassay study.

  1991cited by this paper

• Assessment of intralesional injection of botulinum toxin type A in hypertrophic scars and keloids: Clinical and pathological study

  2022cites this paper